Device Trial Radar · NCT02990793
Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder
Last checked: Nov 19, 2026Latest source record: Jan 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
158
Actual
Start
Apr 4, 2022
Primary completion
Sep 18, 2025
Study completion Nov 4, 2025
Sponsor
- Lead sponsor
- Wave NeuroscienceNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Texas A&M University; GilpinPhillips BIOMED, LLC; Peachtree BioResearch Solutions
- First posted
- Dec 13, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder
Conditions
- PostTraumatic Stress Disorder
- Traumatic Brain Injury
- Postconcussive Symptoms
Interventions
Active MeRT TreatmentDevice
A personalized biometrics-guided protocol known as magnetic EEG/ECG resonance therapy (MeRT) treatment that is tailored specifically to each participant's EEG intrinsic alpha frequency (IAF). rTMS is applied at the participant's IAF.
Sham MeRT TreatmentDevice
rTMS coil does not emit magnetic stimulation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in PTSD SymptomsTime frame: Five weeks
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
BrainHealth Solutions
Costa Mesa, California
VA Long Beach Healthcare System
Long Beach, California
SoCal Neuroscience Research Unit
San Diego, California
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.